Need immediate assistance? Call 1-518-730-0559 (Us-Canada Toll Free) or Contact Us

 

Infant Clinical Nutrition Market: APEJ Continues to be at the Forefront of Demand Globally

Press release Description

Albany, New York, June 4, 2018: A new business intelligence study titled, “Global Market Study on Infant Clinical Nutrition: APEJ to Account for Largest Revenue Share of the Market during 2017 to 2026” has been added to the repository of Market Research Reports Search Engine (MRRSE). According to the report, the global infant clinical nutrition market is likely to reach a valuation of nearly US$ 31 Bn by the end of the forecast period.

According to the report, emphasis and investment on developing effective infant clinical nutrition products has gained steam over the years, as the importance of adequate nutrition in warding off diseases has dawned upon everyone. Robust growth rates, focus on decreasing malnutrition, combined with developments in effective infant clinical nutrition have all contributed to the growth of the market. The researchers are focusing on developing customized rather than generic offerings that will help in the overall cognitive and physical development of infants and toddlers. Considering the scale of interest in this field, it is highly likely that the market will witness steady growth during the assessment period.

The research study offers holistic analysis and insights on various parameters, such as route of administration, product type, and region. According to the report, enteral administration continues to witness steady growth, albeit from a low base. On the other hand, oral route of administration continues to account for the largest revenue share of the market. The report finds that oral route of administration will continue to account for the leading revenue share in the market.

By product type, milk-based infant clinical nutrition products are likely to remain dominant in the market. Milk-based clinical nutrition products are projected to account for the leading revenue share in the market, followed by soy-based and organic products.

Asia Pacific excluding Japan (APEJ) is likely to remain one of the leading markets for infant clinical nutrition globally. The market in APEJ is likely to remain concentrated in China and India, owing to the huge market for these products. In addition to APEJ, North America continues to be a lucrative market in terms of product innovation.

The competitive landscape section in the market is more focused towards research, innovation, and investments. According to the study, some of the leading companies operating in the market include Claris Lifesciences Ltd., B. Braun Melsungen AG, Meiji Co., Ltd., Nutricia North America, Mead Johnson Nutrition Company, Groupe Danone, Baxter International, Inc., Fresenius Kabi AG, Nestlé Health Science S.A., and Abbott.

Browse Full Global Infant Clinical Nutrition Market Report with TOC : https://www.mrrse.com/infant-clinical-nutrition-market

Market Research Reports Search Engine (MRRSE) is an industry-leading database of market intelligence reports. MRRSE is driven by a stellar team of research experts and advisors trained to offer objective advice. Our sophisticated search algorithm returns results based on the report title, geographical region, publisher, or other keywords.

MRRSE partners exclusively with leading global publishers to provide clients single-point access to top-of-the-line market research. MRRSE’s repository is updated every day to keep its clients ahead of the next new trend in market research, be it competitive intelligence, product or service trends or strategic consulting.

Contact

State Tower
90, State Street
Suite 700
Albany, NY – 12207
United States

Telephone: +1-518-730-0559
Email: sales@mrrse.com